Service agreement
Ended Awarded Last action
- Contract number
- 75N91024F00001
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,238
Award facts
- Contract value 33% obligated
-
- $6,237.90 Current, with exercised options
- $18,713.70 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a service agreement contract to Promega Corporation valued at $18,713.70 on February 1, 2024, with completion targeted for January 31, 2027. This contract is structured as a Blanket Purchase Agreement (BPA) call under Promega's existing $10 million NIH BPA vehicle and employs firm fixed price pricing. The work will be performed at Promega's operations in Bethesda, Maryland. No small business set-aside designation was applied to this award, consistent with Promega's status as a large business capable of meeting complex government research requirements.
Promega Corporation, a global life sciences manufacturer headquartered in Madison, Wisconsin, specializes in biological research, diagnostic, and forensic products including DNA analysis systems, molecular diagnostic tools, and specialized laboratory reagents and equipment. The company has an established history of supplying advanced scientific instruments and consumables to multiple federal agencies including the NIH, Centers for Disease Control and Prevention, Defense Health Agency, Food and Drug Administration, and Federal Bureau of Investigation. This NCI call represents procurement activity under the broader NIH BPA vehicle, which covers biological materials, chemicals, medical and scientific equipment, and maintenance services to support the institute's research missions.
Quick answers
Who was awarded contract 75N91024F00001?
75N91024F00001 was awarded to Promega Corporation by National Cancer Institute (National Institutes of Health) on February 1, 2024.
How much is contract 75N91024F00001 worth?
The government has obligated $6,238 on 75N91024F00001. Its potential value, with all options, is $18,714.
Is contract 75N91024F00001 an order under another contract?
Yes. 75N91024F00001 is a BPA call under 75N98024A00046, a blanket purchase agreement.
Was contract 75N91024F00001 competed?
The extent of competition for 75N91024F00001 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award